A New Leamon Boy…..

April 4th, 2014

As some of you may know, our oldest boy, Parker (Wyatt’s older brother), has Type1 Diabetes.  He was diagnosed at age 6, about two years after our little Wyatt passed away.   Parker and Wyatt share the same Autoimmune “family” of disease that has plagued our family.

Toward the end of last year, we got serious about a new venture in our lives.  We decided to put down a deposit for a “scent-trained” service dog which will help alert us of Parker’s high & low blood sugars.

After an amazingly successful Fund Raising Campaign for this new addition to our family, we are proud to announce that we are scheduled to pick up our puppy on Easter weekend.   Parker and mom are scheduled to DRIVE (!!) to Salt Lake City, UT to get this amazing little dude that we know will change our lives in so many ways.

So many of you have followed our journey of life after losing Wyatt so I wanted to share what this new family member means to us.   Unfortunately, when Wyatt’s little body turned on him from an allergic reaction to amoxicillin, we had no option but to respond “reactively” to his autoimmune hepatitis diagnosis.   Sadly, there was not enough time for our boy.   And while we do not adhere to the “things happening for a reason” philosophy, we do believe in the importance of learning from our experiences.

For our Parker, this scent trained dog (who will be able to help us detect highs & lows in his blood sugar based on the scent of Parker’s breath) will be another one of those “Proactive” measures to help Parker live a happier, fuller life!   Parker has been on an insulin pump for about a year and we have plans to get him on a continuous glucose monitor soon.   This new pup will add to the list of life-saving efforts that we are committed to in our family.   Even with all these allies to combat Type1 Diabetes, we will still see swings in Parker’s blood sugar.  It’s just the nature of the beast.

Thank you for all of your support~we are thankful to share our journey with all of you!

-Trisha

Comments are closed.